The impact of national centralized drug procurement policy on firm performance: Evidence from Chinese pharmaceutical firms
Transportation Research Part E: Logistics and Transportation Review · 2025-08 · 200 · 104225
DOI: 10.1016/j.tre.2025.104225 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transportation Research Part E: Logistics and Transportation Review, 2025-08. Verfasst von Huan He und 4 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 100 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
He, H., Zhan, Y., Huo, B., Zhang, Y., & Shi, X. (2025). The impact of national centralized drug procurement policy on firm performance: Evidence from Chinese pharmaceutical firms. Transportation Research Part E: Logistics and Transportation Review, 200, 104225. https://doi.org/10.1016/j.tre.2025.104225
Vancouver
He H, Zhan Y, Huo B, Zhang Y, Shi X. The impact of national centralized drug procurement policy on firm performance: Evidence from Chinese pharmaceutical firms. Transportation Research Part E: Logistics and Transportation Review. 2025;200:104225. doi:10.1016/j.tre.2025.104225
BibTeX
@article{He2025,
author = {He, Huan and Zhan, Yuanzhu and Huo, Baofeng and Zhang, Yufeng and Shi, Xiaojie},
title = {The impact of national centralized drug procurement policy on firm performance: Evidence from Chinese pharmaceutical firms},
journal = {Transportation Research Part E: Logistics and Transportation Review},
year = {2025},
volume = {200},
pages = {104225},
doi = {10.1016/j.tre.2025.104225}
}
EUVIMED